Interim President · Arcturus Therapeutics Holdings Inc. (ARCT)

Mark Herbert

FY2018 is the first fiscal year CompBrief holds for Mark Herbert as a named executive officer of Arcturus Therapeutics; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$460,800

Salary $307,200Stock awards $0

3rd of 4 named executive officers at Arcturus Therapeutics by FY2018 total.

4 named officers on file for Arcturus Therapeutics, FY2018

Mark Herbert’s pay file — $29

  • 1 fiscal year of pay, line by line
  • ARCT’s disclosed peer group of 15 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Arcturus Therapeutics’s whole pay program stands against its peers

  • Arcturus Therapeutics’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on ARCT→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed October 1, 2019 (DEF 14A).

Free

Get Mark Herbert’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Mark Herbert compensation by year

Arcturus Therapeutics Summary Compensation Table · the one fiscal year held
In US dollars, as Arcturus Therapeutics reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$307,200
Bonus$0
Stock awards$0
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$153,600
Total$460,800

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcturus Therapeutics Holdings Inc. DEF 14A filed October 1, 2019, accession 0001193125-19-259220, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Arcturus Therapeutics Holdings Inc. filed document, accession 0001193125-19-259220. Every figure is read from that document and cited to the page and table it appears in. Filed October 1, 2019.

Arcturus Therapeutics’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Joseph PaynePresident and Chief Executive Officer, Director$2,687,044
Padmanabh ChivukulaChief Scientific Officer and Chief Operating Officer$1,372,905
Mark Herbert · this pageInterim President$460,800
Andy SassineInterim Chief Financial Officer$246,340

The full Arcturus Therapeutics compensation record

free company brief

This page is one person within Arcturus Therapeutics's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Arcturus Therapeutics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Mark Herbert's compensation dossier · One-time report. No refunds.